The Chantix Lawsuit
Chantix (varenicline) was approved by the U.S. Food and Drug Administration in 2006 as a medical aid for breaking a nicotine addiction. The medication was quickly embraced by health care community as a welcome option for smoking cessation. Chantix is designed to block receptors stimulated by nicotine, thereby reducing the desire to smoke cigarettes. The brain is an extraordinarily complex organ and – according to several medical research studies and allegations contained in lawsuits – Chantix was soon linked to severe psychological and physical side effects.
The FDA and Chantix
The FDA has become increasingly concerned about the large number of complaints about Chantix side effects made to the agency’s Adverse Event reporting program. In 2009 and 2011 the FDA directed Pfizer (Chantix’s manufacturer) to post new warnings about the dangers of suicidal behavior and heart problems associated with use of the drug. In one of the agency’s harshest wordings, the FDA informed the public of the following:
It appears increasingly likely that there may be an association between Chantix and serious neuropsychiatric symptoms.
Because of the serious side effects attributed to the medication, many smokers who turned to Chantix to wean off their nicotine habit have now taken part in a nationwide wave of lawsuits consolidated before a federal judge.
Contact us for a free evaluation of the legal options that may be available to your if you or a loved one has suffered any of the following side effects as a result of using Chantix to quit smoking:
- Suicide or thoughts of suicide
- Heart attacks or other cardiac problems
Our legal team is well-versed in laws affecting defective drugs and the intricacies of state and federal lawsuits. Please contact us as soon as possible for a free consultation about eligibility to file a Chantix lawsuit.